Last reviewed · How we verify
Streptococcal Endocarditis
Approved treatments
- Cefaprin · Bristol-Myers Squibb
- Penicillin G Potassium In Plastic Container · Pfizer
- Vancocin · ANI Pharmaceuticals
- Unasyn · Bristol-Myers Squibb
- penicillin · Karlstad University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Streptococcal Endocarditis patent landscape — cliff calendar, originator estates, attackable patents
- Streptococcal Endocarditis treatment landscape brief
- Streptococcal Endocarditis treatment updates RSS
Frequently asked questions about Streptococcal Endocarditis
What drugs treat Streptococcal Endocarditis?
Tracked treatments include Cefaprin, Penicillin G Potassium In Plastic Container, Vancocin, Unasyn, penicillin.
What is the treatment for Streptococcal Endocarditis?
Standard treatment for Streptococcal Endocarditis includes Cefaprin, Penicillin G Potassium In Plastic Container, Vancocin, Unasyn, penicillin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Streptococcal Endocarditis patent cliff · Streptococcal Endocarditis CI report
- Treatment: Cefaprin · Bristol-Myers Squibb
- Treatment: Penicillin G Potassium In Plastic Container · Pfizer
- Treatment: Vancocin · ANI Pharmaceuticals
- Treatment: Unasyn · Bristol-Myers Squibb
- Treatment: penicillin · Karlstad University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing